MedTrace Logo

Allogeneic Umbilical Cord Blood Therapy in Children With CP

NCT02025972 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-10-12

No results posted yet for this study

Summary

This open-label study aims to analyze cytokines related to clinical outcomes of allogeneic umbilical cord blood therapy for children with cerebral palsy.

Conditions

  • Cerebral Palsy

Interventions

PROCEDURE

Allogeneic umbilical cord blood therapy

Sponsors & Collaborators

  • CHA University

    collaborator OTHER

  • MinYoung Kim, M.D.

    lead OTHER

Principal Investigators

  • MinYoung Kim, M.D., Ph.D. · CHA University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2015-11-15
Completion
2015-11-15

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02025972 on ClinicalTrials.gov